Autopsy report · NCT04742348

Research on Translational Outcomes of Alcohol (Project RETRO)

“COVID-19 and expiration of funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

University of Washington

Sponsor type

University, hospital or other

Conditions

Alcohol Drinking

Interventions

Carbidopa Levodopa; Placebo

Participants

0

Trials that died the same way

• RESIST-2: 2nd-line ART for HIV-2 Infection
  “COVID-19 and Funding” (85% match in meaning)
• High Risk Outpatient Intern-led Care (HeROIC) Clinic Initiative
  “Covid-19, funding” (84% match in meaning)
• Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury
  “COVID-19 global pandemic, and study funding period ended 7/31/2020.” (77% match in meaning)
• Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device
  “Lack of funding/Covid-19” (73% match in meaning)
• A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
  “The study was terminated early due to the COVID-19 pandemic and sponsor's funding constraints, based on promising preliminary safety and efficacy data.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.